WebMD Health Corp. (NASDAQ:WBMD) Chairman Martin J. Wygod sold 89,843 shares of the stock in a transaction that occurred on Monday, November 21st. The stock was sold at an average price of $53.94, for a total transaction of $4,846,131.42. Following the completion of the transaction, the chairman now owns 156,591 shares in the company, valued at approximately $8,446,518.54. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

WebMD Health Corp. (NASDAQ:WBMD) opened at 53.81 on Friday. The firm has a market capitalization of $2.02 billion, a P/E ratio of 30.06 and a beta of 0.34. WebMD Health Corp. has a 1-year low of $43.36 and a 1-year high of $67.55. The company has a 50-day moving average price of $51.57 and a 200 day moving average price of $56.27.

WebMD Health Corp. (NASDAQ:WBMD) last released its quarterly earnings results on Tuesday, November 1st. The company reported $0.47 EPS for the quarter, topping the consensus estimate of $0.40 by $0.07. The company had revenue of $171.40 million for the quarter, compared to analyst estimates of $169.96 million. WebMD Health Corp. had a return on equity of 35.64% and a net margin of 11.97%. The firm’s revenue was up 12.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.32 earnings per share. Analysts expect that WebMD Health Corp. will post $1.91 earnings per share for the current fiscal year.

WBMD has been the topic of several research reports. Zacks Investment Research upgraded shares of WebMD Health Corp. from a “hold” rating to a “buy” rating and set a $57.00 price target on the stock in a report on Thursday, October 20th. Leerink Swann restated a “buy” rating on shares of WebMD Health Corp. in a research report on Wednesday, September 28th. Mizuho restated a “buy” rating and issued a $68.00 price objective on shares of WebMD Health Corp. in a research report on Wednesday, August 10th. Citigroup Inc. upped their price objective on WebMD Health Corp. from $62.00 to $64.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 9th. Finally, Goldman Sachs Group Inc. restated a “neutral” rating and issued a $62.00 price objective on shares of WebMD Health Corp. in a research report on Thursday, August 11th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and two have assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $64.29.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD raised its position in WebMD Health Corp. by 12.7% in the third quarter. Price T Rowe Associates Inc. MD now owns 477,650 shares of the company’s stock worth $23,739,000 after buying an additional 53,640 shares during the last quarter. LPL Financial LLC raised its position in WebMD Health Corp. by 11.9% in the third quarter. LPL Financial LLC now owns 12,307 shares of the company’s stock worth $610,000 after buying an additional 1,306 shares during the last quarter. Cornerstone Capital Management Holdings LLC. raised its position in WebMD Health Corp. by 131.7% in the third quarter. Cornerstone Capital Management Holdings LLC. now owns 48,655 shares of the company’s stock worth $2,417,000 after buying an additional 27,655 shares during the last quarter. Ameritas Investment Partners Inc. raised its position in WebMD Health Corp. by 66.4% in the third quarter. Ameritas Investment Partners Inc. now owns 15,029 shares of the company’s stock worth $747,000 after buying an additional 5,995 shares during the last quarter. Finally, Global Alpha Capital Management Ltd. raised its position in WebMD Health Corp. by 7.0% in the third quarter. Global Alpha Capital Management Ltd. now owns 83,900 shares of the company’s stock worth $4,170,000 after buying an additional 5,500 shares during the last quarter. 84.44% of the stock is currently owned by institutional investors and hedge funds.